Published in Scand J Thorac Cardiovasc Surg on January 01, 1996
Randomized study of basal-bolus insulin therapy in the inpatient management of patients with type 2 diabetes undergoing general surgery (RABBIT 2 surgery). Diabetes Care (2011) 3.06
Prevalence and clinical outcome of hyperglycemia in the perioperative period in noncardiac surgery. Diabetes Care (2010) 1.93
Management of type 2 diabetes: evolving strategies for the treatment of patients with type 2 diabetes. Metabolism (2011) 1.41
The influence of general health status and social support on symptomatic outcome following coronary artery bypass grafting. Heart (2001) 0.91
The effect of diabetes mellitus on short term mortality and morbidity after isolated coronary artery bypass grafting surgery. Int Cardiovasc Res J (2013) 0.79
Lumbar spinal stenosis: conservative or surgical management?: A prospective 10-year study. Spine (Phila Pa 1976) (2000) 3.69
Determination of pressure gradient in mitral stenosis with a non-invasive ultrasound Doppler technique. Acta Med Scand (1976) 3.65
Skin cancer in kidney and heart transplant recipients and different long-term immunosuppressive therapy regimens. J Am Acad Dermatol (1999) 3.19
The Oslo balloon angioplasty versus conservative treatment study (OBACT)--the 2-years results of a single centre, prospective, randomised study in patients with intermittent claudication. Eur J Vasc Endovasc Surg (2006) 2.74
Lumbar spinal stenosis. Clinical and radiologic features. Spine (Phila Pa 1976) (1995) 2.37
Determination of cardiac output by Doppler echocardiography. Br Heart J (1984) 2.31
Tranexamic acid (Cyklokapron) is not necessary to reduce blood loss after coronary artery bypass operations. J Thorac Cardiovasc Surg (1993) 2.25
Antiphospholipid antibodies after myocardial infarction and their relation to mortality, reinfarction, and non-haemorrhagic stroke. Lancet (1992) 2.22
Follow-up and final results of the Oslo I Study comparing screen-film mammography and full-field digital mammography with soft-copy reading. Acta Radiol (2005) 2.16
High-intensity interval training improves peak oxygen uptake and muscular exercise capacity in heart transplant recipients. Am J Transplant (2012) 2.08
The association between the proximal extension of the clot and the severity of pulmonary embolism (PE): a proposal for a new radiological score for PE. J Intern Med (2007) 2.07
Thrombolytic therapy for acute myocardial infarction in older patients. Lancet (1996) 2.03
Sternal wound infections in patients undergoing open heart surgery: randomized study comparing intracutaneous and transcutaneous suture techniques. Ann Thorac Surg (2001) 2.00
Fasting blood glucose: an underestimated risk factor for cardiovascular death. Results from a 22-year follow-up of healthy nondiabetic men. Diabetes Care (1999) 1.82
CXC-chemokines, a new group of cytokines in congestive heart failure--possible role of platelets and monocytes. Cardiovasc Res (2000) 1.74
Prolonged thromboprophylaxis following hip replacement surgery--results of a double-blind, prospective, randomised, placebo-controlled study with dalteparin (Fragmin) Thromb Haemost (1997) 1.73
Association of mannose-binding-lectin deficiency with severe atherosclerosis. Lancet (1998) 1.62
Myocardial gene expression of leukaemia inhibitory factor, interleukin-6 and glycoprotein 130 in end-stage human heart failure. Eur J Clin Invest (2001) 1.55
Clopidogrel increases expression of chemokines in peripheral blood mononuclear cells in patients with coronary artery disease: results of a double-blind placebo-controlled study. J Thromb Haemost (2006) 1.55
Myocardial expression of CC- and CXC-chemokines and their receptors in human end-stage heart failure. Cardiovasc Res (2000) 1.53
Osteoprotegerin concentrations and prognosis in acute ischaemic stroke. J Intern Med (2009) 1.53
Enhanced levels of soluble and membrane-bound CD40 ligand in patients with unstable angina. Possible reflection of T lymphocyte and platelet involvement in the pathogenesis of acute coronary syndromes. Circulation (1999) 1.53
Lymphoid infiltration and prognosis in colorectal carcinoma. Br J Cancer (1984) 1.52
Omega-3 fatty acids improve blood pressure control and preserve renal function in hypertensive heart transplant recipients. Eur Heart J (2001) 1.51
Extracorporeal membrane oxygenation using a centrifugal pump and a servo regulator to prevent negative inlet pressure. Ann Thorac Surg (1997) 1.50
Cytokine network in congestive heart failure secondary to ischemic or idiopathic dilated cardiomyopathy. Am J Cardiol (1999) 1.50
Viral safety of solvent/detergent-treated plasma. Transfusion (2000) 1.46
Elevated circulating levels of C-C chemokines in patients with congestive heart failure. Circulation (1998) 1.46
Everolimus initiation and early calcineurin inhibitor withdrawal in heart transplant recipients: a randomized trial. Am J Transplant (2014) 1.46
Management of suspected pulmonary embolism (PE) by D-dimer and multi-slice computed tomography in outpatients: an outcome study. J Thromb Haemost (2005) 1.45
Virtual histology assessment of cardiac allograft vasculopathy following introduction of everolimus--results of a multicenter trial. Am J Transplant (2012) 1.45
Mortality and morbidity after coronary artery bypass surgery related to pre-operative left ventricular ejection fraction: a follow-up study. Eur Heart J (1996) 1.41
Determination of effective orifice area in mitral stenosis from non-invasive ultrasound Doppler data and mitral flow rate. Acta Med Scand (1977) 1.41
[Immunomodulating treatment in advanced heart failure--effect of intravenous immunoglobulin]. Tidsskr Nor Laegeforen (2001) 1.40
Coronary artery-left ventricle fistula. AJR Am J Roentgenol (1989) 1.40
Mechanical valve replacement in congenital heart disease. J Heart Valve Dis (1996) 1.40
Fluid balance and pulmonary functions during and after coronary artery bypass surgery: Ringer's acetate compared with dextran, polygeline, or albumin. Acta Anaesthesiol Scand (1995) 1.39
Immunomodulating therapy with intravenous immunoglobulin in patients with chronic heart failure. Circulation (2001) 1.29
Cardiopulmonary exercise testing and prognosis in severe heart failure: 14 mL/kg/min revisited. Am Heart J (2000) 1.28
Clinical, hemodynamic, and cardiopulmonary exercise test determinants of survival in patients referred for evaluation of heart failure. Ann Intern Med (1998) 1.26
The effect of free fatty acids on myocardial oxygen consumption during atrial pacing and catecholamine infusion in man. Circulation (1978) 1.26
Interaction between chemokines and oxidative stress: possible pathogenic role in acute coronary syndromes. J Am Coll Cardiol (2001) 1.18
Content and distribution of macrophages and lymphocytes in solid malignant human tumours. Int J Cancer (1979) 1.17
Effect of dietary supplementation with n-3 fatty acids on coronary artery bypass graft patency. Am J Cardiol (1996) 1.15
Fatty acid composition of adipose tissue in male Norwegians with myocardial infarction. Acta Med Scand (1972) 1.14
Transportation of critically ill patients on extracorporeal membrane oxygenation. Perfusion (2008) 1.11
Increasing incidence of ventricular septal defects caused by improved detection rate. Acta Paediatr (1994) 1.09
Strut fracture in the new Bjørk-Shiley mitral valve prosthesis. Thorac Cardiovasc Surg (1981) 1.08
Undercarboxylated matrix Gla protein is associated with indices of heart failure and mortality in symptomatic aortic stenosis. J Intern Med (2010) 1.08
Plasma N-terminal proatrial natriuretic factor can predict normal pulmonary capillary wedge pressure in cardiac transplant recipients. Scand Cardiovasc J (2001) 1.07
AT1 and AT2 angiotensin receptor gene expression in human heart failure. Circulation (1997) 1.07
[Intermittent claudication and beta-blockaders. An unfortunate combination?]. Tidsskr Nor Laegeforen (1995) 1.07
Luminal loss and restenosis after coronary angioplasty. The role of lipoproteins and lipids. Eur Heart J (1999) 1.06
Association between intraoperative cerebral microembolic signals and postoperative neuropsychological deficit: comparison between patients with cardiac valve replacement and patients with coronary artery bypass grafting. J Neurol Neurosurg Psychiatry (1998) 1.05
Cyclosporin A inhibits cardiac hypertrophy and enhances cardiac dysfunction during postinfarction failure in rats. Am J Physiol Heart Circ Physiol (2000) 1.05
Risk factors in primary sclerosing cholangitis. J Hepatol (1994) 1.04
K+ shifts of skeletal muscle during stepwise bicycle exercise with and without beta-adrenoceptor blockade. J Physiol (1994) 1.04
Surgical treatment of recurrent ventricular tachycardia. Br Heart J (1973) 1.02
Effect of nifedipine (Adalat) on coronary haemodynamics in patients with coronary arteriosclerotic disease. Acta Med Scand (1978) 1.01
Complement activation in patients with congestive heart failure: effect of high-dose intravenous immunoglobulin treatment. Circulation (2001) 1.01
Doppler echocardiographic measurement of cardiac output using the mitral orifice method. Br Heart J (1985) 1.00
Intraaortic balloon pump in open heart operations: 10-year follow-up with risk analysis. Ann Thorac Surg (1998) 1.00
Demonstration of platelet-derived microvesicles in blood from patients with activated coagulation and fibrinolysis using a filtration technique and western blotting. Thromb Haemost (1994) 1.00
Enhanced gene expression of chemokines and their corresponding receptors in mononuclear blood cells in chronic heart failure--modulatory effect of intravenous immunoglobulin. J Am Coll Cardiol (2001) 1.00
Verapamil and pulmonary hypertension. Acta Med Scand (1978) 0.99
In situ analysis of the inflammatory cell infiltrates in colon carcinomas and in the normal colon wall. Acta Pathol Microbiol Immunol Scand A (1982) 0.99
Heparin-coated cardiopulmonary bypass equipment. I. Biocompatibility markers and development of complications in a high-risk population. J Thorac Cardiovasc Surg (1999) 0.99
Chronic intravascular haemolysis after aortic disc valve replacement. Comparative study between Lillehei-Kaster and Björk-Shiley disc valve prostheses. Br Heart J (1974) 0.99
Cerebral microembolic signals during cardiopulmonary bypass surgery. Frequency, time of occurrence, and association with patient and surgical characteristics. Stroke (1997) 0.98
Isolation and characterization of lymphocytes and macrophages from solid, malignant human tumours. Int J Cancer (1979) 0.98
Natriuretic peptides in patients with aortic stenosis. Am Heart J (2001) 0.97
Haemolysis after mitral valve replacement with the Björk-Shiley and the Lillehei-Kaster disc valve prosthesis. Br Heart J (1976) 0.97
Ultrasonic assessment of abdominal venous return. I. Effect of cardiac action and respiration on mean velocity pattern, cross-sectional area and flow in the inferior vena cava and portal vein. Acta Radiol Diagn (Stockh) (1986) 0.96
Poisoning with ethylene glycol monomethyl ether. Report of two cases. Acta Med Scand (1970) 0.96
[Are the results of thallium scintigraphy and coronary angiography equivalent? An evaluation of thallium scintigraphies performed at Vestfold Central Hospital]. Tidsskr Nor Laegeforen (1993) 0.96
Effects of cognitive therapy versus interpersonal psychotherapy in patients with major depressive disorder: a systematic review of randomized clinical trials with meta-analyses and trial sequential analyses. Psychol Med (2011) 0.96
Chemokines in myocardial failure -- pathogenic importance and potential therapeutic targets. Clin Exp Immunol (2001) 0.95
Levels of circulating adhesion molecules in congestive heart failure and after heart transplantation. Am J Cardiol (1998) 0.94